Atalanta Therapeutics Inc

Atalanta Therapeutics, Inc. develops biotechnology solutions focused on RNA interference therapeutics for neurological diseases. The company advances a proprietary di-siRNA platform for gene silencing in the central nervous system and pursues collaborations and clinical trials for disease-modifying therapies. It serves patients with neurological and neurodegenerative diseases in the US.